Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition
Business Wire (Fri, 15-May 7:00 AM ET)
Nu Skin’s Strategic Moves Highlight Early Signs of Stability Amid Revenue Pressures
Market Chameleon (Fri, 8-May 4:49 AM ET)
Nu Skin Enterprises Reports First Quarter Results
Business Wire (Thu, 7-May 4:06 PM ET)
Nu Skin Enterprises Announces Quarterly Dividend
Business Wire (Thu, 7-May 4:05 PM ET)
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
Nu Skin Enterprises trades on the NYSE stock market under the symbol NUS.
As of July 17, 2026, NUS stock price declined to $5.34 with 49,637 million shares trading.
NUS has a beta of 1.56, meaning it tends to be more sensitive to market movements. NUS has a correlation of 0.12 to the broad based SPY ETF.
NUS has a market cap of $259.26 million. This is considered a Small Cap stock.
Last quarter Nu Skin Enterprises reported $321 million in Revenue and $.14 earnings per share. This fell short of revenue expectation by $-9 million and missed earnings estimates by -$.01.
In the last 3 years, NUS traded as high as $30.30 and as low as $4.89.
The top ETF exchange traded funds that NUS belongs to (by Net Assets): AVUV, VTI, IWM, FNDA, VDC.
NUS has underperformed the market in the last year with a return of -32.6%, while the SPY ETF gained +20.7%. In the last 3 month period, NUS fell short of the market, returning -29.4%, while SPY returned +6.5%. However, in the most recent 2 weeks NUS has outperformed the stock market by returning +6.6%, while SPY returned +0.1%.
NUS support price is $5.21 and resistance is $5.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUS shares will trade within this expected range on the day.
